Maria Otano, MD
Family Medicine · St Petersburg, FLNPI 1720571714
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Viiv Healthcare Company at 41.3% of the total. Reporting peaked in 2022 at $800 and has fallen 92.9% since, to $56 in 2024.
Across 41 payments — averaging $25.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$428
- Gilead$266
- AbbVie$132
- Theratechnologies Inc.$92
- Organon$39
- Johnson & Johnson$27
- plus $53 from 3 others
What the payments were for
- Food & beverage$97294%
- Education$656%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 13 | $428 |
| Gilead | 12 | $266 |
| AbbVie | 6 | $132 |
| Theratechnologies Inc. | 3 | $92 |
| Organon | 2 | $39 |
| Johnson & Johnson | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $17 |
| VBI Vaccine (delaware) Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,037 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $49,268 |
| TrulicityDulaglutide | 12 | $13,287 |
| JanuviaSitagliptin Phosphate | 12 | $11,985 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $1,859 |
| Insulin Lispro Protamine MixInsulin Lispro Protamin/Lispro | 11 | $1,648 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 12 | $711 |
| Diclofenac Sodium | 17 | $569 |
| Atorvastatin Calcium | 40 | $543 |
| Nifedipine ErNifedipine | 16 | $512 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $504 |
| Famotidine | 28 | $382 |
| Rosuvastatin Calcium | 44 | $337 |
| Montelukast Sodium | 11 | $327 |
| Gabapentin | 26 | $320 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 27 | $290 |
Paid to pharmacies, not to this prescriber.
Other family medicine in St Petersburg
- Edward BraunSt Petersburg$364K
- Robert WallaceSt Petersburg$144K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.